Market Cap : 64.42 B | Enterprise Value : 63.55 B | PE Ratio : 44.99 | PB Ratio : 10.83 |
---|
NYSE:EW has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:EW has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Edwards Lifesciences has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.
Good Sign:
Edwards Lifesciences Corp shows strong financial strength.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.GuruFocus does not calculate Edwards Lifesciences's interest coverage with the available data. Edwards Lifesciences's debt to revenue ratio for the quarter that ended in Jun. 2022 was 0.12. As of today, Edwards Lifesciences's Altman Z-Score is 18.32.
For the Medical Devices subindustry, Edwards Lifesciences's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Financial Strength distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Edwards Lifesciences's Interest Expense for the months ended in Jun. 2022 was $0 Mil. Its Operating Income for the months ended in Jun. 2022 was $445 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $660 Mil.
Edwards Lifesciences's Interest Coverage for the quarter that ended in Jun. 2022 is
GuruFocus does not calculate Edwards Lifesciences's interest coverage with the available data. |
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Edwards Lifesciences Corp has enough cash to cover all of its debt. Its financial situation is stable.
2. Debt to revenue ratio. The lower, the better.
Edwards Lifesciences's Debt to Revenue Ratio for the quarter that ended in Jun. 2022 is
Debt to Revenue Ratio | = | Total Debt (Q: Jun. 2022 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (23.3 | + | 659.5) | / | 5495.6 | |
= | 0.12 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Edwards Lifesciences has a Z-score of 18.32, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 18.32 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Edwards Lifesciences has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.
Thank you for viewing the detailed overview of Edwards Lifesciences's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Laviolette Paul A | director | ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 |
Sequeira Ramona | director | ONE EDWARDS WAY IRVINE CA 92614 |
Chopra Daveen | officer: CVP, Surgical Structural Heart | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92618 |
Lemercier Jean-luc M | officer: CVP, EMEA, Canada, Latin Amer | C/O ONE EDWARDS WAY IRVINE CA 92614 |
Ullem Scott B. | officer: CVP, CFO | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Bobo Donald E Jr | officer: CVP,Strategy/Corp Development | C/O EDWARDS LIFESCIENCES ONE EDWARDS WAY IRVINE CA 92614 |
Szyman Catherine M. | officer: CVP, Critical Care | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Sellers Robert W.a. | officer: VP, Corp. Controller (Principa | ONE EDWARDS WAY IRVINE CA 92614 |
Stone Heisz Leslie | director | C/O PUBLIC STORAGE 701 WESTERN AVENUE GLENDALE CA 91201 |
Loranger Steven R | director | XYLEM. INC. 1133 WESTCHESTER AVENUE WHITE PLAINS NY 10604 |
Zovighian Bernard J | officer: CVP, Surgical Heart Valves | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Marsh Martha H. | director | 9769 WEXFORD CIRCLE GRANITE BAY CA 95746 |
Gallahue Kieran | director | PO BOX 684369 PARK CITY UT 84068 |
Valeriani Nicholas J | director | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Mccauley Christine Z | officer: CVP, Human Resources | ONE EDWARDS WAY IRVINE CA 92614 |
Other Sources
By Zacks 2022-03-25
By Zacks 2022-03-01
By Zacks 2022-04-01
By Zacks 2022-04-05
By Zacks 2022-03-14
By tipranks.com 2022-02-11
By tipranks.com 2022-02-25
By Zacks 2022-01-27
By Zacks 2022-03-30
By Zacks 2022-04-04
By Zacks 2022-01-26
By Zacks 2022-03-28